Cód QR

Prognostic and predictive impact of NOTCH1 mutations in patients with chronic lymphocytic leukemia: a tertiary single-center experience

NOTCH1 mutations (NOTCH1m) occur in 6%–12% of newly diagnosed chronic lymphocytic leukemia (CLL) patients, increasing to 15%–20% in relapsed cases. Despite their clinical relevance, the independent prognostic impact of NOTCH1m remains controversial, particularly in the era of targeted therapies, and...

Cur síos iomlán

Sábháilte in:
Príomhchruthaitheoirí: Mattia D’Antiga, Andrea Serafin, Francesco Angotzi, Alessandro Cellini, Arianna Bevilacqua, Giovanni Leone, Nicolò Danesin, Chiara Adele Cavarretta, Francesco Piazza, Erich Piovan, Laura Bonaldi, Livio Trentin, Andrea Visentin
Formáid: Artigo
Teanga:Inglês
Foilsithe / Cruthaithe: Frontiers Media S.A. 2026-01-01
Sraith:Frontiers in Oncology
Ábhair:
CLL
NOTCH1
overall survival
prognostic factors
target therapy
Rochtain ar líne:https://www.frontiersin.org/articles/10.3389/fonc.2025.1726439/full
Clibeanna: Cuir clib leis
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!

Míreanna comhchosúla